Expanding on previous hypotheses that associate the role of blood cell-derived vesicles to the alterations of the circulating lipidome of COVID-19 (+) patients as a function of disease severity, as gleaned by IL-6 levels and pre-existing conditions (e.g., obesity)11. The gene discussed is IL6; the disease is COVID-19.